Gene: TRIQK
Official Full Name: triple QxxK/R motif containingprovided by HGNC
Gene Summary: Predicted to be located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13038 | TRIQK Knockout cell line (HeLa) | Human | TRIQK | 1:3~1:6 | Negative | Online Inquiry |
KO13039 | TRIQK Knockout cell line (HCT 116) | Human | TRIQK | 1:2~1:4 | Negative | Online Inquiry |
KO13040 | TRIQK Knockout cell line (HEK293) | Human | TRIQK | 1:3~1:6 | Negative | Online Inquiry |
KO13041 | TRIQK Knockout cell line (A549) | Human | TRIQK | 1:3~1:4 | Negative | Online Inquiry |
TRIQK Gene Knockout Cell Lines are a sophisticated suite of genetically engineered cellular models designed to facilitate targeted gene disruption studies. These cell lines utilize a reliable and efficient CRISPR/Cas9 system to precisely knockout specific genes, allowing researchers to explore gene function, disease pathways, and therapeutic targets with enhanced accuracy and reproducibility.
The key mechanism of TRIQK Gene Knockout Cell Lines involves the introduction of single-guide RNA (sgRNA) that directs the Cas9 nuclease to specific genomic locations, resulting in the creation of double-strand breaks. The repair processes then lead to insertions or deletions that disrupt the target gene’s coding sequence, effectively silencing its expression. This powerful approach enables the examination of the biological implications stemming from gene loss, providing invaluable insights into various cellular processes, including cell proliferation, differentiation, and response to stimuli.
In research and clinical applications, TRIQK Gene Knockout Cell Lines are instrumental in the investigation of disease models, gene function validation, and drug discovery initiatives. The ability to create customized knockout cell lines tailored to specific research needs enhances their utility across various fields, including oncology, neurobiology, and immunology.
What sets TRIQK Gene Knockout Cell Lines apart from alternative products is their high specificity, efficiency, and the seamless integration of control lines, which allow for robust experimental designs and reproducibility. Additionally, the user-friendly protocols and comprehensive support from our expert team ensure that researchers can easily adopt these innovative models into their workstreams.
Researchers and clinicians will find tremendous value in TRIQK Gene Knockout Cell Lines due to their capacity to accelerate discovery, propel forward translational research, and enhance the understanding of complex biological systems. Our commitment to scientific excellence and innovation positions us as a leader in the development of cutting-edge genetic tools, ensuring our customers have access to the most advanced biological research solutions available.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.